SBC Medical Group Holdings Inc (SBC) stock
SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 12/3039% below fair value
$5.34+0.10 (+1.91%)
Close on Nov 12, 2026Market cap $549.20MP/E 11.4Yield –
SBC Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
SBC Medical's ebitda for the twelve months ending Jun 30, 2026 was $68.63M, up 13.4% year over year. For fiscal 2025 it was $70.17M, down 5.3% from the year before.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $70.17M | -5.3% |
| FY2024 | Dec 31, 2024 | $74.10M | -10.6% |
| FY2023 | Dec 31, 2023 | $82.91M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $20.09M | +32.3% |
| Q1 FY2026 | Mar 31, 2026 | $18.39M | -25.9% |
| Q4 FY2025 | Dec 31, 2025 | $13.52M | +139.4% |
| Q3 FY2025 | Sep 30, 2025 | $16.63M | +11.9% |
| Q2 FY2025 | Jun 30, 2025 | $15.19M | -46.0% |
| Q1 FY2025 | Mar 31, 2025 | $24.83M | -2.5% |
| Q4 FY2024 | Dec 31, 2024 | $5.65M | -78.7% |
| Q3 FY2024 | Sep 30, 2024 | $14.85M | – |
| Q2 FY2024 | Jun 30, 2024 | $28.12M | – |
| Q1 FY2024 | Mar 31, 2024 | $25.48M | – |
| Q4 FY2023 | Dec 31, 2023 | $26.55M | – |
See a number that looks wrong?